{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:02:16Z","timestamp":1789970536208,"version":"4.0.1"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Holmium\/thulium laser enucleation of the prostate (LEP) is an established, size-independent surgical option for benign prostatic hyperplasia, while Aquablation is an emerging robotic waterjet therapy. Until recently, the two had never been compared in a randomized head-to-head trial, and the only prior quantitative synthesis relied on an indirect, transurethral resection of the prostate (TURP)-anchored network comparison. We conducted the first pairwise meta-analysis restricted to studies directly comparing Aquablation and LEP, incorporating the first partially randomized head-to-head trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      PubMed, Embase, Cochrane Library, and Scopus were searched for studies directly comparing Aquablation with HoLEP or thulium enucleation, following PRISMA 2020 and AMSTAR 2. The complete search strings for each database, the date of the final search, language and date restrictions, and the duplicate removal process. Outcomes were pooled using random-effects (DerSimonian\u2013Laird) models as mean differences (MD) for continuous and risk ratios (RR) for dichotomous variables; outcomes exceeding\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      of 95% were reported narratively rather than pooled. Prespecified subgroup analyses stratified studies by prostate volume, and a large propensity-matched claims database reporting 30- and 90-day safety outcomes was analyzed separately. Sensitivity analyses restricted to prospective studies and excluding higher-risk studies were performed to examine robustness.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 126 records identified, 7 full-text articles were assessed for eligibility and 1 (ATHLETE) was excluded as a study protocol with no outcome data, leaving 6 studies: 1 partially randomized trial, 4 comparative cohorts (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009845 total), and 1 claims database (2,104 matched patients). Overall symptom relief did not differ significantly [International Prostate Symptom Score (IPSS) MD \u22120.93, 95% CI \u22122.13 to 0.27], though Aquablation showed a non-significant numerical trend in large glands (MD \u22121.21, 95% CI \u22122.51 to 0.08; exploratory subgroup, k\u2009=\u20092). Laser enucleation provided superior deobstruction, with higher maximum flow rate (Qmax MD \u22125.66\u2005mL\/s, \u22127.64 to \u22123.69), lower post-void residual (MD +11.96\u2005mL), and greater tissue removal (residual prostate volume MD +23.4\u2005mL). Aquablation markedly reduced ejaculatory dysfunction (RR 0.19, 0.11\u20130.32), an effect preserved across gland sizes. Operative time and hemoglobin drop showed extreme heterogeneity and were not pooled. Aquablation was associated with higher 30- and 90-day hospital readmission and catheter reinsertion rates in the claims database, but lower urinary tract infection at 90\u2005days.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>No statistically significant difference in overall symptom relief was observed between Aquablation and laser enucleation, though a non-significant numerical trend in large glands is exploratory and requires confirmation. Aquablation confers markedly better, size-independent ejaculatory preservation, while laser enucleation provides superior objective deobstruction. Certainty of evidence remains low to moderate given the limited partially randomized base and short follow-up. These findings support an individualized choice between procedures based on gland size and patient priorities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?ID=CRD420261439112<\/jats:ext-link>\n                      , PROSPERO CRD420261439112.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fsurg.2026.1937749","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:36:50Z","timestamp":1789969010000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Aquablation versus laser enucleation of the prostate for benign prostatic hyperplasia: a systematic review and pairwise meta-analysis of head-to-head studies including the first randomized trial"],"prefix":"10.3389","volume":"13","author":[{"given":"Mohammad Zaid","family":"Jarai","sequence":"first","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Elmekresh","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaikha","family":"Alshamsi","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalla","family":"Aboelkheir","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadhel","family":"Yusuf","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Abdul Hamid","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Agha","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Alyammahi","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thureya","family":"Binashour","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murtadha","family":"Altammam","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Eldesouki","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Jayakumar","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kais","family":"Kotiesh","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hassan","family":"Al Hamad","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafe","family":"Alhayek","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmunem","family":"Mohsen","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthil","family":"Subramanian","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salam","family":"AlHasani","sequence":"additional","affiliation":[{"name":"Department of Urology, Mediclinic Welcare Hospital","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariborz","family":"Bagheri","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser","family":"Saeedi","sequence":"additional","affiliation":[{"name":"Department of Urology, Dubai Hospital, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.juro.2009.11.034","article-title":"Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia","volume":"183","author":"Krambeck","year":"2010","journal-title":"J Urol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.juro.2011.06.065","article-title":"Holmium laser enucleation of the prostate: long-term durability of clinical outcomes and complication rates during 10 years of followup","volume":"186","author":"Elmansy","year":"2011","journal-title":"J Urol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.juro.2017.12.065","article-title":"WATER: a double-blind, randomized, controlled trial of Aquablation vs. transurethral resection of the prostate for benign prostatic hyperplasia","volume":"199","author":"Gilling","year":"2018","journal-title":"J Urol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/JU.0000000000003483","article-title":"Aquablation therapy in large prostates (80\u2013150mL) for lower urinary tract symptoms due to benign prostatic hyperplasia: final WATER II 5-year clinical trial results","volume":"210","author":"Bhojani","year":"2023","journal-title":"J Urol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/bco2.454","article-title":"Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: a network meta-analysis","volume":"5","author":"Bhatia","year":"2024","journal-title":"BJUI Compass"},{"key":"B6","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews","volume":"358","author":"Shea","year":"2017","journal-title":"Br Med J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"B9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.euf.2026.01.006","article-title":"WATER III: a prospective, partially randomized trial of Aquablation therapy versus transurethral laser enucleation of the prostate for treatment of lower urinary tract symptoms","volume":"12","author":"Ritter","year":"2026","journal-title":"Eur Urol Focus"},{"key":"B10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/10926429251393894","article-title":"Aquablation for benign prostatic hyperplasia: a prospective study with comparative analysis of transurethral resection of the prostate and holmium laser enucleation","volume":"36","author":"Perez","year":"2026","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"B11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.23736\/S2724-6051.24.05871-3","article-title":"Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study","volume":"77","author":"Justo Quintas","year":"2025","journal-title":"Minerva Urol Nephrol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.4111\/icu.20250055","article-title":"Aquablation versus HoLEP: propensity score matching analysis of functional outcomes and ejaculation preservation","volume":"66","author":"Oh","year":"2025","journal-title":"Investig Clin Urol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s00345-024-04997-0","article-title":"Aquablation versus HoLEP in patients with benign prostatic hyperplasia: a comparative prospective non-randomized study","volume":"42","author":"Michaelis","year":"2024","journal-title":"World J Urol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1177\/08927790251364272","article-title":"Comparative analysis of 30- and 90-day outcomes of Aquablation vs. other surgical treatments for benign prostatic hyperplasia","volume":"39","author":"Florissi","year":"2025","journal-title":"J Endourol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"B16","first-page":"10685","article-title":"Aquablation with subsequent selective bipolar cauterization versus holmium laser enucleation of the prostate (HoLEP) with regard to perioperative bleeding","volume":"28","author":"Gloger","year":"2021","journal-title":"Can J Urol"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1937749\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:36:50Z","timestamp":1789969010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1937749\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":16,"alternative-id":["10.3389\/fsurg.2026.1937749"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2026.1937749","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"article-number":"1937749"}}